Epigenetic Signaling of Cancer Stem Cells During Inflammation

Malignant tumors pose a great challenge to human health, which has led to many studies increasingly elucidating the tumorigenic process. Cancer Stem Cells (CSCs) have profound impacts on tumorigenesis and development of drug resistance. Recently, there has been increased interest in the relationship between inflammation and CSCs but the mechanism underlying this relationship has not been fully elucidated. Inflammatory cytokines produced during chronic inflammation activate signaling pathways that regulate the generation of CSCs through epigenetic mechanisms. In this review, we focus on the effects of inflammation on cancer stem cells, particularly the role of signaling pathways such as NF-kappa B pathway, STAT3 pathway and Smad pathway involved in regulating epigenetic changes. We hope to provide a novel perspective for improving strategies for tumor treatment.

Automated summary

Chronic inflammation activates signaling pathways through inflammatory cytokines, regulating the generation of CSCs via epigenetic mechanisms, with the mechanism still not fully elucidated. Understanding the relationship between inflammation and cancer stem cells is important for improving tumor treatment strategies.